Skip Navigation U.S. Department of Health and Human Services
Agency for Healthcare Research Quality
Archive print banner

This information is for reference purposes only. It was current when produced and may now be outdated. Archive material is no longer maintained, and some links may not work. Persons with disabilities having difficulty accessing this information should contact us at: Let us know the nature of the problem, the Web address of what you want, and your contact information.

Please go to for current information.

Table 1.53a
Percent of heart failure patients with left ventricular systolic dysfunction prescribed ACE inhibitor or angiotensin receptor blocker at discharge, all payers, United States, 2005
Population group 2005
Percent Standard error
Total   82.9 0.4
Gender Male 82.4 0.1
Female 83.0 0.1
Race White 81.4 0.1
Black 85.4 0.1
Hispanic 82.9 0.3
Native American 85.8 1.0
Asian 81.5 0.6
Age Under 65 86.8 0.1
65-74 81.8 0.1
75-84 80.2 0.1
85 and over 78.5 0.2

Key: ACE: angiotensin converting enzyme.

Source: Centers for Medicare & Medicaid Services, Medicare Quality Improvement Organization Program.


The information on this page is archived and provided for reference purposes only.


AHRQ Advancing Excellence in Health Care